Journal

Atherosclerosis
ISSN: 1879-1484
Titre abrégé: Atherosclerosis
Pays: Ireland
ID NLM: 0242543

Informations de publication

Date de publication:
03 2020
Historique:
received: 05 12 2019
revised: 18 01 2020
accepted: 14 02 2020
pubmed: 1 3 2020
medline: 7 4 2021
entrez: 1 3 2020
Statut: ppublish

Résumé

Molecular imaging with We performed FDG and NaF PET/CT imaging in two clinically similar cohorts of patients living with HIV (PLWH) with no symptomatic cardiovascular disease. The prevalence and intensity of coronary artery uptake of each tracer, measured as target-to-background ratio (TBR), were assessed in patients at low and high cardiovascular risk. Ninety-three PLWH were submitted to PET/CT imaging with FDG (N = 43) and NaF (N = 50); 42% were at low and 58% at high cardiovascular risk. The intensity of uptake and multivessel coronary artery uptake were significantly higher with NaF than FDG both in low and high-risk patients. When each The prevalence of coronary artery uptake was higher with NaF compared to FDG both in high and low risk patients, hence microcalcification imaging may be a more sensitive tool to detect coronary atherosclerosis than inflammation imaging. However, the uptake of each

Sections du résumé

BACKGROUND AND AIMS
Molecular imaging with
METHODS
We performed FDG and NaF PET/CT imaging in two clinically similar cohorts of patients living with HIV (PLWH) with no symptomatic cardiovascular disease. The prevalence and intensity of coronary artery uptake of each tracer, measured as target-to-background ratio (TBR), were assessed in patients at low and high cardiovascular risk.
RESULTS
Ninety-three PLWH were submitted to PET/CT imaging with FDG (N = 43) and NaF (N = 50); 42% were at low and 58% at high cardiovascular risk. The intensity of uptake and multivessel coronary artery uptake were significantly higher with NaF than FDG both in low and high-risk patients. When each
CONCLUSIONS
The prevalence of coronary artery uptake was higher with NaF compared to FDG both in high and low risk patients, hence microcalcification imaging may be a more sensitive tool to detect coronary atherosclerosis than inflammation imaging. However, the uptake of each

Identifiants

pubmed: 32113050
pii: S0021-9150(20)30094-0
doi: 10.1016/j.atherosclerosis.2020.02.014
pii:
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D
Sodium Fluoride 8ZYQ1474W7

Types de publication

Comparative Study Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

127-135

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declared they do not have anything to disclose regarding conflict of interest with respect to this manuscript.

Auteurs

Giovanni Guaraldi (G)

Modena HIV Metabolic Clinic, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Jovana Milic (J)

Modena HIV Metabolic Clinic, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Napoleone Prandini (N)

Department of Nuclear Medicine, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Guido Ligabue (G)

Department of Radiology, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Francesco Esposito (F)

Modena HIV Metabolic Clinic, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Giacomo Ciusa (G)

Modena HIV Metabolic Clinic, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Andrea Malagoli (A)

Modena HIV Metabolic Clinic, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Riccardo Scaglioni (R)

Department of Radiology, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Giulia Besutti (G)

Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41124, Modena, Italy; Department of Radiology, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Barbara Beghetto (B)

Modena HIV Metabolic Clinic, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Giulia Nardini (G)

Modena HIV Metabolic Clinic, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Enrica Roncaglia (E)

Modena HIV Metabolic Clinic, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Cristina Mussini (C)

Modena HIV Metabolic Clinic, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, 41124, Modena, Italy.

Paolo Raggi (P)

Division of Cardiology and Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, 11220, 83rd Avenue, Suite 5A9-014, Edmonton, AB T6G 2B7, Canada. Electronic address: raggi@ualberta.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH